LentiGlobin BB305

Here's Why Bluebird Bio Turned in a Disappointing 2015
Motley Fool
Sat, 01/9/16 - 10:40 am
Bluebird Bio
LentiGlobin BB305
Bluebird bio builds its case for gene therapy as first sickle cell patient responds
Fierce Biotech
Sat, 06/13/15 - 09:42 am
Bluebird Bio
sickle cell disease
LentiGlobin BB305
gene therapy
Bluebird beats a path to early approval for its pioneering gene therapy
Fierce Biotech
Tue, 05/19/15 - 10:43 am
Bluebird Bio
gene therapy
LentiGlobin BB305
Could These Experimental Drugs Eclipse Harvoni's Historic Launch?
Motley Fool
Mon, 03/30/15 - 11:13 am
drug launches
Bluebird Bio
LentiGlobin BB305
aducanumab
Biogen Idec
Gilead Sciences
Harvoni
Gene therapy pioneer Bluebird bags a 'breakthrough' title for lead program
Fierce Biotech
Mon, 02/2/15 - 08:08 am
Bluebird Bio
gene therapy
beta-thalassemia
LentiGlobin BB305